FILTER
FILTERED INTERVIEW RESULTS
Dr. Andrea Pfeifer
CO-FOUNDER & CEO, AC IMMUNE
AC Immune describes its research into neurodegenerative diseases.
Mark Egerton
CEO, QUOTIENT SCIENCES
Quotient Sciences is a drug development and manufacturing accelerator that supports pharmaceutical and biotech companies with services spanning the entire development pathway from candidate selection to commercial launch.
Jay Shukla
PRESIDENT & CEO, NIVAGEN PHARMACEUTICALS, INC.
Nivagen Pharmaceuticals provides complete research, analytical formulation development, and regulatory support.
Dr. Jagadeesh Babu Rangisetty
FOUNDER & CEO, BIOPHORE
Biophore explains how it is expanding productions of different APIs to ensure both quality and supply chain security.
James Gale
CEO, SIGNET HEALTHCARE PARTNERS
Signet Healthcare Partners speaks to GBR about how it is evolving its’ investment portfolio in life sciences.
Emer Leahy
PRESIDENT AND CEO, PSYCHOGENICS
PsychoGenics explains how CNS is attracting unprecedented attention and how its AI-driven phenotypic discovery platforms can help to deliver cures.
Keith Crandell
CO-FOUNDER & MANAGING DIRECTOR, ARCH VENTURE PARTNERS
ARCH Venture Partners explains the secrets to successful innovation in todays’ life sciences.
Daniel J. O’Connor
PRESIDENT & CEO, ONCOSEC MEDICAL INCORPORATED
OnoSec Medical explains how treating cancers with a plasmid-based approach can avoid side effects and work on immunologically cold tumors.
Jorge Nogueira
CEO, DIPHARMA FRANCIS
Dipharma speaks to GBR of how it is adapting to market trends and expanding its geography.
Peter Meath
CO-HEAD OF HEALTHCARE AND LIFE SCIENCES, MIDDLE MARKET, J.P. MORGAN COMMERCIAL BANKING
"While the underlying business model for life sciences companies hasn’t changed as a result of our current environment, we’re seeing that increased capital has been made available to those seeking funding. This makes it an incredibly promising time for the sector."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Africa Energy 2025
GBR is pleased to release its Africa Energy 2025 report, following four months of interviews and research across Sub-Saharan Africa, during which time we met with over 120 companies, including those in the upstream, midstream, and downstream sectors, as well as governments, financiers, and service providers.
GBR is pleased to release its Africa Energy 2025 report, following four months of interviews and research across Sub-Saharan Africa, during which time we met with over 120 companies, including those in the upstream, midstream, and downstream sectors, as well as governments, financiers, and service providers.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
